Is pharmacogenetic testing ready for antidepressant treatment? A cost-effectiveness simulation

被引：1
|
作者：
Olgiati, P. [1 ]
Serretti, A. [1 ]
Bigelli, M. [1 ]
De Ronchi, D. [1 ]
Bajo, E. [1 ]
机构：
[1] Univ Bologna, Bologna, Italy
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2011年 / 21卷
关键词：
D O I：
10.1016/S0924-977X(11)70625-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S389 / S389
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF PHARMACOGENETIC TESTING TO GUIDE TREATMENT IN SCHIZOPHRENIA
    Khani, Noushin Saadullah
    Murtough, Stephen
    Richards-Belle, Alvin
    Varney, Lauren
    Cotic, Marius
    Abidoph, Rosemary
    Barrett, Barbara
    Jin, Huajie
    Bramon, Elvira
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2024, 87 : 253 - 253
  • [2] When is Pharmacogenetic Testing for Antidepressant Response Ready for the Clinic? A Cost-effectiveness Analysis Based on Data from the STAR*D Study
    Perlis, Roy H.
    Patrick, Amanda
    Smoller, Jordan W.
    Wang, Philip S.
    NEUROPSYCHOPHARMACOLOGY, 2009, 34 (10) : 2227 - 2236
  • [3] When is Pharmacogenetic Testing for Antidepressant Response Ready for the Clinic? A Cost-effectiveness Analysis Based on Data from the STAR*D Study
    Roy H Perlis
    Amanda Patrick
    Jordan W Smoller
    Philip S Wang
    Neuropsychopharmacology, 2009, 34 : 2227 - 2236
  • [4] Cost-effectiveness of antidepressant treatment
    Head, L
    OKeane, V
    BRITISH JOURNAL OF PSYCHIATRY, 1997, 171 : 88 - 88
  • [5] Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment
    D F Heitjan
    D A Asch
    Riju Ray
    Margaret Rukstalis
    Freda Patterson
    C Lerman
    The Pharmacogenomics Journal, 2008, 8 : 391 - 399
  • [6] Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment
    Heitjan, D. F.
    Asch, D. A.
    Ray, Riju
    Rukstalis, Margaret
    Patterson, Freda
    Lerman, C.
    PHARMACOGENOMICS JOURNAL, 2008, 8 (06): : 391 - 399
  • [7] Cost-effectiveness of antidepressant treatment reassessed
    Woods, SW
    Rizzo, JA
    BRITISH JOURNAL OF PSYCHIATRY, 1997, 170 : 257 - 263
  • [8] Cost-effectiveness of pharmacogenetic testing to predict treatment response to angiotensin-converting enzyme inhibitor
    Costa-Scharplatz, Madlaina
    van Asselt, Antoinette D. I.
    Bachmann, Lucas M.
    Kessels, Alfons G. H.
    Severens, Johan L.
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (05): : 359 - 368
  • [9] Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
    M Verbelen
    M E Weale
    C M Lewis
    The Pharmacogenomics Journal, 2017, 17 : 395 - 402
  • [10] Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
    Verbelen, M.
    Weale, M. E.
    Lewis, C. M.
    PHARMACOGENOMICS JOURNAL, 2017, 17 (05): : 395 - 402
12345